☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Lipid modification guideline update

The National Institute for Health and Clinical Excellence has issued an update to the Lipid Modification Guideline relating to recommendations on methods of cardiovascular risk estimation.

The original guideline recommended using a Framingham based risk estimation tool however recent developments in the evidence comparing different risk estimation tools has resulted in no single tool having a clear advantage.

As a result clinicians can now consider using QRISK or Framingham-based tools. In Scotland, clinicians are already advised to use ASSIGN when estimating cardiovascular risk.

Action: Clinicians should be aware of this update and consider which risk prediction tool should be used in practice. Whichever tool is used, clinicians should be aware of any limitations and corrections required in use.

Share 'Lipid modification guideline update' by emailShare 'Lipid modification guideline update' on FacebookShare 'Lipid modification guideline update' on TwitterShare 'Lipid modification guideline update' on LinkedInShare 'Lipid modification guideline update' on reddit


No Comments to “Lipid modification guideline update”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.